Homologous up-regulation of vitamin D receptors is tissue specific in the rat

Robert C. Gensure, Steve D. Antrobus, John Fox, Martina Okwueze, Stephanie Y. Talton, Marian R. Walters

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

1,25-dihydroxyvitamin D3 (1,25(OH)2D3) receptors (VDR) are expressed in multiple tissues within the body. VDR levels are increased by 1,25(OH)2D3 in intestine and kidney and in numerous cell models. The ability of 1,25(OH)2D3 to affect VDR levels in other target tissues in vivo was studied by assessing VDR levels by the 3H-1,25(OH)2D3 binding assay under varied physiological conditions in the rat. When compared with vitamin D-deficient (-D) controls, rats raised on a normal vitamin D-sufficient (+D) diet showed elevated VDR levels in kidney (391 ± 53 vs. 913 ± 76 fmol/g of tissue; p < 0.05), but not in testis, heart, or lung. Up-regulation of the VDR also occurred in kidney of +D rats I day after a single 100-ng dose of 1,25(OH)2D3 (454 ± 43 vs. 746 ± 113 fmol/mg of DNA; p < 0.05), but no changes were seen in intestine, testis, or lung. Because 1,25(OH)2D3- induced hypercalcemia may independently affect VDR regulation, 1,25(OH)2D3 was infused into -D rats, and normocalcemia was maintained by reduced dietary calcium intake. In this model, the renal VDR was again up-regulated (446 ± 115 vs. 778 ± 58 fmol/mg of DNA;p < 0.05), but VDR levels in testis and lung were unaffected. Scatchard analysis and tests of 1,25(OH)2D3 dose (1-100 ng/day for 7 days) and temporal (100 ng/day for 1-7 days) responsiveness further supported the tissue-specific nature of the homologous VDR regulation. Assay of VDR levels by L-1-tosylamido-2-phenylethyl chloromethyl ketone-3H-1,25(OH)2D3 exchange assay ruled out differences in endogenous 1,25(OH)2D3 occupancy as the basis for the observed differences in VDR regulation. Finally, coidentity of the VDR-like sites in kidney versus testis was confirmed by competitive binding analysis comparing their relative affinities for 25(OH)D3 versus 1,25(OH)2D3 (30.5 ± 6.4 vs. 35.6 ± 3.6 in kidney and testis, respectively) and by immunoblot analysis using a highly specific monoclonal anti-rat VDR antibody. Thus, under a wide variety of experimental conditions, homologous up-regulation of the VDR occurs in the rat kidney in vivo, but not in several other target tissues which do not regulate plasma calcium homeostasis. Moreover, this differential VDR regulation did not result from secondary changes in plasma calcium, from differential 1,25(OH)2D3 responsiveness in the various tissues, nor from differences in endogenous 1,25(OH)2D3 occupancy of the VDR. These studies thus establish that, in contrast to observations in vitro, the widely described phenomenon of homologous VDR up-regulation in kidney and intestine is not a universal property of 1,25(OH)2D3 target tissues in vivo in the rat.

Original languageEnglish (US)
Pages (from-to)454-463
Number of pages10
JournalJournal of Bone and Mineral Research
Volume13
Issue number3
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Calcitriol Receptors
Up-Regulation
Kidney
Testis
Intestines
Vitamin D
Lung
Calcium
Dietary Calcium
Competitive Binding
Calcitriol
DNA
Hypercalcemia
Ketones
Homeostasis
Diet
Antibodies

ASJC Scopus subject areas

  • Surgery

Cite this

Gensure, R. C., Antrobus, S. D., Fox, J., Okwueze, M., Talton, S. Y., & Walters, M. R. (1998). Homologous up-regulation of vitamin D receptors is tissue specific in the rat. Journal of Bone and Mineral Research, 13(3), 454-463. https://doi.org/10.1359/jbmr.1998.13.3.454

Homologous up-regulation of vitamin D receptors is tissue specific in the rat. / Gensure, Robert C.; Antrobus, Steve D.; Fox, John; Okwueze, Martina; Talton, Stephanie Y.; Walters, Marian R.

In: Journal of Bone and Mineral Research, Vol. 13, No. 3, 1998, p. 454-463.

Research output: Contribution to journalArticle

Gensure, RC, Antrobus, SD, Fox, J, Okwueze, M, Talton, SY & Walters, MR 1998, 'Homologous up-regulation of vitamin D receptors is tissue specific in the rat', Journal of Bone and Mineral Research, vol. 13, no. 3, pp. 454-463. https://doi.org/10.1359/jbmr.1998.13.3.454
Gensure, Robert C. ; Antrobus, Steve D. ; Fox, John ; Okwueze, Martina ; Talton, Stephanie Y. ; Walters, Marian R. / Homologous up-regulation of vitamin D receptors is tissue specific in the rat. In: Journal of Bone and Mineral Research. 1998 ; Vol. 13, No. 3. pp. 454-463.
@article{f61a28f4d76e414fb1f12250591fd826,
title = "Homologous up-regulation of vitamin D receptors is tissue specific in the rat",
abstract = "1,25-dihydroxyvitamin D3 (1,25(OH)2D3) receptors (VDR) are expressed in multiple tissues within the body. VDR levels are increased by 1,25(OH)2D3 in intestine and kidney and in numerous cell models. The ability of 1,25(OH)2D3 to affect VDR levels in other target tissues in vivo was studied by assessing VDR levels by the 3H-1,25(OH)2D3 binding assay under varied physiological conditions in the rat. When compared with vitamin D-deficient (-D) controls, rats raised on a normal vitamin D-sufficient (+D) diet showed elevated VDR levels in kidney (391 ± 53 vs. 913 ± 76 fmol/g of tissue; p < 0.05), but not in testis, heart, or lung. Up-regulation of the VDR also occurred in kidney of +D rats I day after a single 100-ng dose of 1,25(OH)2D3 (454 ± 43 vs. 746 ± 113 fmol/mg of DNA; p < 0.05), but no changes were seen in intestine, testis, or lung. Because 1,25(OH)2D3- induced hypercalcemia may independently affect VDR regulation, 1,25(OH)2D3 was infused into -D rats, and normocalcemia was maintained by reduced dietary calcium intake. In this model, the renal VDR was again up-regulated (446 ± 115 vs. 778 ± 58 fmol/mg of DNA;p < 0.05), but VDR levels in testis and lung were unaffected. Scatchard analysis and tests of 1,25(OH)2D3 dose (1-100 ng/day for 7 days) and temporal (100 ng/day for 1-7 days) responsiveness further supported the tissue-specific nature of the homologous VDR regulation. Assay of VDR levels by L-1-tosylamido-2-phenylethyl chloromethyl ketone-3H-1,25(OH)2D3 exchange assay ruled out differences in endogenous 1,25(OH)2D3 occupancy as the basis for the observed differences in VDR regulation. Finally, coidentity of the VDR-like sites in kidney versus testis was confirmed by competitive binding analysis comparing their relative affinities for 25(OH)D3 versus 1,25(OH)2D3 (30.5 ± 6.4 vs. 35.6 ± 3.6 in kidney and testis, respectively) and by immunoblot analysis using a highly specific monoclonal anti-rat VDR antibody. Thus, under a wide variety of experimental conditions, homologous up-regulation of the VDR occurs in the rat kidney in vivo, but not in several other target tissues which do not regulate plasma calcium homeostasis. Moreover, this differential VDR regulation did not result from secondary changes in plasma calcium, from differential 1,25(OH)2D3 responsiveness in the various tissues, nor from differences in endogenous 1,25(OH)2D3 occupancy of the VDR. These studies thus establish that, in contrast to observations in vitro, the widely described phenomenon of homologous VDR up-regulation in kidney and intestine is not a universal property of 1,25(OH)2D3 target tissues in vivo in the rat.",
author = "Gensure, {Robert C.} and Antrobus, {Steve D.} and John Fox and Martina Okwueze and Talton, {Stephanie Y.} and Walters, {Marian R.}",
year = "1998",
doi = "10.1359/jbmr.1998.13.3.454",
language = "English (US)",
volume = "13",
pages = "454--463",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Homologous up-regulation of vitamin D receptors is tissue specific in the rat

AU - Gensure, Robert C.

AU - Antrobus, Steve D.

AU - Fox, John

AU - Okwueze, Martina

AU - Talton, Stephanie Y.

AU - Walters, Marian R.

PY - 1998

Y1 - 1998

N2 - 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) receptors (VDR) are expressed in multiple tissues within the body. VDR levels are increased by 1,25(OH)2D3 in intestine and kidney and in numerous cell models. The ability of 1,25(OH)2D3 to affect VDR levels in other target tissues in vivo was studied by assessing VDR levels by the 3H-1,25(OH)2D3 binding assay under varied physiological conditions in the rat. When compared with vitamin D-deficient (-D) controls, rats raised on a normal vitamin D-sufficient (+D) diet showed elevated VDR levels in kidney (391 ± 53 vs. 913 ± 76 fmol/g of tissue; p < 0.05), but not in testis, heart, or lung. Up-regulation of the VDR also occurred in kidney of +D rats I day after a single 100-ng dose of 1,25(OH)2D3 (454 ± 43 vs. 746 ± 113 fmol/mg of DNA; p < 0.05), but no changes were seen in intestine, testis, or lung. Because 1,25(OH)2D3- induced hypercalcemia may independently affect VDR regulation, 1,25(OH)2D3 was infused into -D rats, and normocalcemia was maintained by reduced dietary calcium intake. In this model, the renal VDR was again up-regulated (446 ± 115 vs. 778 ± 58 fmol/mg of DNA;p < 0.05), but VDR levels in testis and lung were unaffected. Scatchard analysis and tests of 1,25(OH)2D3 dose (1-100 ng/day for 7 days) and temporal (100 ng/day for 1-7 days) responsiveness further supported the tissue-specific nature of the homologous VDR regulation. Assay of VDR levels by L-1-tosylamido-2-phenylethyl chloromethyl ketone-3H-1,25(OH)2D3 exchange assay ruled out differences in endogenous 1,25(OH)2D3 occupancy as the basis for the observed differences in VDR regulation. Finally, coidentity of the VDR-like sites in kidney versus testis was confirmed by competitive binding analysis comparing their relative affinities for 25(OH)D3 versus 1,25(OH)2D3 (30.5 ± 6.4 vs. 35.6 ± 3.6 in kidney and testis, respectively) and by immunoblot analysis using a highly specific monoclonal anti-rat VDR antibody. Thus, under a wide variety of experimental conditions, homologous up-regulation of the VDR occurs in the rat kidney in vivo, but not in several other target tissues which do not regulate plasma calcium homeostasis. Moreover, this differential VDR regulation did not result from secondary changes in plasma calcium, from differential 1,25(OH)2D3 responsiveness in the various tissues, nor from differences in endogenous 1,25(OH)2D3 occupancy of the VDR. These studies thus establish that, in contrast to observations in vitro, the widely described phenomenon of homologous VDR up-regulation in kidney and intestine is not a universal property of 1,25(OH)2D3 target tissues in vivo in the rat.

AB - 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) receptors (VDR) are expressed in multiple tissues within the body. VDR levels are increased by 1,25(OH)2D3 in intestine and kidney and in numerous cell models. The ability of 1,25(OH)2D3 to affect VDR levels in other target tissues in vivo was studied by assessing VDR levels by the 3H-1,25(OH)2D3 binding assay under varied physiological conditions in the rat. When compared with vitamin D-deficient (-D) controls, rats raised on a normal vitamin D-sufficient (+D) diet showed elevated VDR levels in kidney (391 ± 53 vs. 913 ± 76 fmol/g of tissue; p < 0.05), but not in testis, heart, or lung. Up-regulation of the VDR also occurred in kidney of +D rats I day after a single 100-ng dose of 1,25(OH)2D3 (454 ± 43 vs. 746 ± 113 fmol/mg of DNA; p < 0.05), but no changes were seen in intestine, testis, or lung. Because 1,25(OH)2D3- induced hypercalcemia may independently affect VDR regulation, 1,25(OH)2D3 was infused into -D rats, and normocalcemia was maintained by reduced dietary calcium intake. In this model, the renal VDR was again up-regulated (446 ± 115 vs. 778 ± 58 fmol/mg of DNA;p < 0.05), but VDR levels in testis and lung were unaffected. Scatchard analysis and tests of 1,25(OH)2D3 dose (1-100 ng/day for 7 days) and temporal (100 ng/day for 1-7 days) responsiveness further supported the tissue-specific nature of the homologous VDR regulation. Assay of VDR levels by L-1-tosylamido-2-phenylethyl chloromethyl ketone-3H-1,25(OH)2D3 exchange assay ruled out differences in endogenous 1,25(OH)2D3 occupancy as the basis for the observed differences in VDR regulation. Finally, coidentity of the VDR-like sites in kidney versus testis was confirmed by competitive binding analysis comparing their relative affinities for 25(OH)D3 versus 1,25(OH)2D3 (30.5 ± 6.4 vs. 35.6 ± 3.6 in kidney and testis, respectively) and by immunoblot analysis using a highly specific monoclonal anti-rat VDR antibody. Thus, under a wide variety of experimental conditions, homologous up-regulation of the VDR occurs in the rat kidney in vivo, but not in several other target tissues which do not regulate plasma calcium homeostasis. Moreover, this differential VDR regulation did not result from secondary changes in plasma calcium, from differential 1,25(OH)2D3 responsiveness in the various tissues, nor from differences in endogenous 1,25(OH)2D3 occupancy of the VDR. These studies thus establish that, in contrast to observations in vitro, the widely described phenomenon of homologous VDR up-regulation in kidney and intestine is not a universal property of 1,25(OH)2D3 target tissues in vivo in the rat.

UR - http://www.scopus.com/inward/record.url?scp=0031939188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031939188&partnerID=8YFLogxK

U2 - 10.1359/jbmr.1998.13.3.454

DO - 10.1359/jbmr.1998.13.3.454

M3 - Article

C2 - 9525346

AN - SCOPUS:0031939188

VL - 13

SP - 454

EP - 463

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 3

ER -